Merck Vaccine Unit Tops $1 Billion In Second Quarter Sales On Strength Of New Products
This article was originally published in The Pink Sheet Daily
Executive Summary
Gardasil sales, however, were down sequentially compared to the first quarter.
You may also be interested in...
Merck Plans Gardasil Campaign Targeting “Mid-adult” Women
FDA clears Pennsylvania manufacturing plant; vaccine sBLAs, including one for Gardasil in “older” women, can proceed.
Merck Plans Gardasil Campaign Targeting “Mid-adult” Women
FDA clears Pennsylvania manufacturing plant; vaccine sBLAs, including one for Gardasil in “older” women, can proceed.
Merck’s Novel HIV Drug Isentress Granted Six-Month FDA Review
First-in-class integrase inhibitor could see a mid-October approval.